FMP

FMP

Enter

AORT - Artivion, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/AORT.png

Artivion, Inc.

AORT

NYSE

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita Open Plus and E-vita Open Neo. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.

24.12 USD

0.7 (2.9%)

AORT Financial Statements

Year

2024

2023

2022

2021

CF from Operating Activities

22.24M

18.82M

-5.15M

-2.58M

Net Income

-13.36M

-30.69M

-19.19M

-14.83M

Depreciation & Amortization

24.2M

23.08M

22.44M

23.98M

Deferred Income Taxes

-1.51M

-1.39M

-1.72M

-4.47M

Stock Based Compensation

14.24M

14.42M

12.34M

10.71M

Change in Working Capital

0

-16.19M

-25.94M

-33.23M

Accounts Receivable

-15.39M

-4.05M

-13.34M

-11.56M

Inventory

4.43M

-14.36M

-8.4M

-18.38M

Accounts Payable

9.5M

1.68M

-1.96M

-1.89M

Other Working Capital

0

535k

-2.23M

-1.4M

Other Non-Cash Items

-1.34M

29.59M

6.91M

15.26M

CF from Investing Activities

-28.19M

-502k

-10.71M

5.66M

Investments in Property, Plant & Equipment

-11.19M

-7.43M

-10.71M

-13.09M

Net Acquisitions

0

0

0

0

Investment Purchases

0

0

0

0

Sales/Maturities of Investments

0

0

0

19M

Other Investing Activites

-17M

6.93M

-1.7M

-249k

CF from Financing Activities

2.2M

865k

-1.64M

-12.22M

Debt Repayment

-358k

-1.75M

-2.75M

-3.08M

Common Stock Issued

0

0

0

0

Common Stock Repurchased

0

-559k

-1.79M

-1.91M

Dividends Paid

0

0

0

0

Other Financing Activites

2.56M

4.2M

-459k

-7.22M

Free Cash Flow

11.05M

11.39M

-15.87M

-15.68M

Operating Cash Flow

22.24M

18.82M

-5.15M

-2.58M

Capital Expenditures

-11.19M

-7.43M

-10.71M

-13.09M

Cash at Beginning of Period

58.94M

39.35M

55.01M

61.96M

Cash at End of Period

53.46M

58.94M

39.35M

55.01M

Net Change In Cash

-5.48M

19.59M

-15.66M

-6.95M

Retained Earning Schedule

Year

2024

2023

2022

2021

Retained Earnings (Previous Year)

-47.91M

-17.22M

1.98M

20.02M

Net Income

-13.36M

-30.69M

-19.19M

-14.83M

Stock Repurchases

0

-559k

-1.79M

-1.91M

Dividend Paid

0

0

0

0

Retained Earnings

-61.27M

-47.91M

-17.22M

1.98M

Other Distributions

-13.36M

-31.25M

-20.99M

-19.96M

PPE Schedule

Year

2024

2023

2022

2021

Gross PPE

76.13M

82.18M

80.53M

83.23M

Annual Depreciation

24.2M

23.08M

22.44M

23.98M

Capital Expenditure

-11.19M

-7.43M

-10.71M

-13.09M

Net PPE

63.11M

66.53M

68.81M

72.35M

Intangible and Goodwill Schedule

Year

2024

2023

2022

2021

Acquisitions and Adjustments

-6.38M

3.71M

-6.37M

-10.06M

Goodwill (Previous Year)

247.34M

243.63M

250M

260.06M

Goodwill

240.96M

247.34M

243.63M

250M

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep